Your browser doesn't support javascript.
loading
Contribution of direct and indirect recognition pathways to T cell alloreactivity.
Liu, Z; Sun, Y K; Xi, Y P; Maffei, A; Reed, E; Harris, P; Suciu-Foca, N.
Afiliação
  • Liu Z; Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, New York 10032.
J Exp Med ; 177(6): 1643-50, 1993 Jun 01.
Article em En | MEDLINE | ID: mdl-7684431
T cells from an HLA-DR11/DR12 responder were stimulated in mixed lymphocyte culture with cells carrying the DR1 antigen. After priming, T cells proliferated in response to both DR1-positive-stimulating cells and a peptide derived from a polymorphic region of the HLA-DR beta 1*0101 chain presented by responder's antigen-presenting cells (APC). The dominant epitope recognized by the primed T cells corresponded to residue 21-42 and was presented by the responder's HLA-DR12 antigen. The DR1 peptide-reactive T cells express T cell receptor V beta 3. The results demonstrate that allopeptides derived from the processing and presentation of donor major histocompatibility complex molecules by host-derived APC trigger alloreactivity. The frequency of T cells engaged in the indirect pathway of allorecognition is about 100-fold lower than that of T cells participating in the direct recognition of native HLA-DR antigen. However, indirect allorecognition may play an important role in chronic allograft rejection, a phenomenon that is mediated by the activation of T helper cells and of alloantibody-producing B cells.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Antígenos HLA-DR Limite: Humans Idioma: En Ano de publicação: 1993 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Antígenos HLA-DR Limite: Humans Idioma: En Ano de publicação: 1993 Tipo de documento: Article